Bibliography

216

Bibliography

Books:

Agarwal, Jamuna P. (1980). “Determinants of Foreign Direct Investment: A

Survey”, weltwirtschaftliches Archiv, 116 Heft 4.

Buckeye, Peter J. and Mark Casson (1976). “The Future of the MNFs”,

Macmillan, London.

Caves, R.E. (1982). “Multinational Enterprise and Economic Analysis”, Harvard

University, Cambridge University Press.

Chaudhuri, Sudip (2005). “The WTO and India’s Pharmaceutical Industry: Patent

Protection, TRIPs and Developing Countries”, Oxford University Press, New

Delhi.

Chaturvedi, S.K. (2007). “Foreign Investment Laws and its Impact on Labour”,

Deep and Deep Publication, Pvt. Ltd., New Delhi.

Chopra, Chanchal (2004). “Foreign Investment in India: Liberalization and WTO-

The Emerging Scenario”, Deep and Deep Publication Pvt. Ltd., New Delhi.

Cohen, Stephen D. (2007). “MNCs and Foreign Direct Investment- Avoiding

Simplicity, Embracing Complexity”, Oxford University Press.

Correa, Carlos M. (2000). “ Intellectual Property Rights, the WTO and

Developing Countriers: The TRIPS Agreement and Policy Option”, Zen Book

Ltd., London.

Dunning, J.H. & R. Narula (2004). “Multinationals and Industrial

Competitiveness A New Agenda”, Edward Elgar Publishing Limited,

Cheltenham.

Dunning, J.H. (1970). “Studies in International Investments”, The Pitman Press

Bath, George Allen and Unwin Ltd.

Bibliography

217

Dunning, J.H. (1981). “International Production and the Multinational

Enterprises”, Allen and Unwin Ltd.

Dunning, J.H. and Sarianna M. Lundan (2008). “Multinational Enterprises and

the Global Economy”, Edward Elgar Publication Ltd, USA.

Dunning, John H. (1977). “Trade Location of Economic activity and the MNE: A

Search for an Eclectic Approach”, in the International Allocation of Economic

Activity. ed. by B. Ohlin, P.O. Hsselborn and P.T. WiJkman, Macmillan,

London.

Ghakar, Kamlesh (2007). “Foreign Direct Investment in India 1947to 2007:

Policies, Trends and Outlook”, New Century Publication, New Delhi.

Govindaraj, R. and G. Chellaraj (2002). “The Indian Pharmaceutical Sector:

Issues and Options for Health Sector Reforms”, World Bank Publications.

Gujarati, Damodar N. (2005). “Basic Econometrics”, 4th edition, Tata McGraw-

Hill, New Delhi.

Hufbaur, G.C. (1975). “The MNCs and direct investment in International Trade

and Finance: Frontiers of Research”, ed. by Peter B. Kenen, Cambridge

University Press, England.

Johri, L.M. (1983). “Business Strategies of Multinational Corporation: A case

study of Drugs & Pharmaceutical Industry”, Vision Book, New Delhi.

Joshi, Vijay, and I. M. D. Little (1996). “India's Economic Reforms 1991-2001”,

New York, Clarendon Press.

Kidron, Michal (1965). “Foreign Investment in India”, Oxford, London.

Kindleberger, Charles (1992). “International Economics”, Irvin Irwin, London.

Kumar, Nagesh (1994). “Multinational Enterprises and Industrial Organization:

The case of India”, Sage Publication, New Delhi.

Bibliography

218

Martinussen, J. (1988). “Transnational Corporations in a Developing Economy:

The Indian Experience”, Sage Publication, New Delhi.

Narula, Rajesh and S. Lall (eds.) (2006). “Understanding FDI Assisted Economic

Development”, Rutledge, London & New York.

Pradhan, J.P. and P.P. Sahu (2008). “Transnationalization of Indian

Pharmaceutical SMEs”, Bookwell Publishen, New Delhi.

Reekie, W. (1975). “The Economics of the Pharmaceutical Industry”, Macmillan,

London.

Singh, R.K. and V.S.Kulkarni (2006). “FDI and Economic Development”,

Abhijeet Publication, New Delhi.

Singh, S. (1985). “Multinational Corporation and Indian Drug Industry” Criterion

Publication, New Delhi.

Thakur, Anil Kumar and T.K.Shandilya (2007). “FDI in India: Problems and

Prospects”, Deep and Deep Publication Pvt. Ltd., New Delhi.

Todaro, Michael (1999). “Economic Development”, Prentice Hall, Illinois.

Vaitsos, C.V. (1974). “Inter Country Income Distribution and Transnational

Enterprises”, Oxford, Clarenden Press.

Theses / Dissertations:

Adil, Maqbool (1994). “Flow of Foreign Direct Investment from USA to India”,

PhD Thesis, Department of Commerce, AMU, Aligarh.

Ahmad, Khaliq (1985). “Problems and Prospects of the Heavy Drugs Industry in

India”, M.Phil Dissertation, Department of Commerce, AMU, Aligarh.

Ahmad, Khaliq (1987). “Marketing Strategies of Drugs and Pharmaceutical

Industry in the Public Sector”, Ph.D. Thesis, Department of Commerce, AMU,

Aligarh.

Bibliography

219

Alam, Qaiser (2004). “Trends of FDI in Selected Asian Countries during 1990s-

with Special Reference to India”, Ph.D. Thesis, Department of Economics,

AMU, Aligarh.

Chatterjee, Sumana (2009). “An Economic Analysis of Foreign Direct Investment

in India”, Ph.D. Thesis, Department of Economics, Vadodara, Gujarat.

Gupta, R.K. (1974). “Management of Corporate Earnings in Pharmaceutical

Industry”, Ph.D. Thesis, Department of Commerce, University of Delhi, New

Delhi.

Hymer, S.H. (1960). “The International Operations of National Firms: A Study of

Direct Foreign Investment”, Ph.D. Thesis, Massachusetts Institute of

Technology (Published by NIT Press 1976).

Khan, Mohd. Ahsan (2004). “A Study of Foreign Direct Investment inflows in

Automobile Industries in India since Liberalization”, Ph.D. Thesis, Department

of Commerce, AMU, Aligarh.

Kumar, Nagesh (1980). “Evolution of Direct Foreign Investment in India: A Case

Study of Drugs and pharmaceutical Concerns”, M.Phil. Disertation, Department

of Economics, Delhi School of Economics, University of Delhi, New Delhi.

Naved, Asif (1999). “Economic Liberalization and Trends in Foreign Direct

Investment in India”, Ph.D. Thesis, Department of Commerce, AMU, Aligarh.

Rehmani, Suhel A.K. (2000). “Problems and Prospects of the Foreign Direct

Investment in India (A Case Study of US investment)”, Ph.D. Thesis,

Department of Commerce, AMU, Aligarh.

Sahoo, Rajib Kumar (2005). “FDI and Growth of Manufacturing Sector: An

Empirical Study in Post-reform India”, Ph.D. Thesis, Institute of Social

Economic Change, Nagarbhawi, Bangalore (September).

Bibliography

220

Singh, Ajit (2000). “Foreign Investment in India’s Infrastructural Sector since

1991: A Case Study of Power Sector”, Ph.D. Thesis, Department of Commerce,

AMU, Aligarh.

Singh, Neelam (1986). “Foreign Ownership Size and Performance of a firm: A

Case Study of Indian Pharmaceutical Industry”, Ph.D. Thesis, Department of

Economics, Delhi School of Economics, University of Delhi, New Delhi.

Walia, Mini (2009). “A Study of Patent Law and Policy under WTO Regime with

reference to Pharmaceutical Industry in India”, Ph.D. Thesis, Department of

Commerce & Business Studies, Jamia Millia Islamia, New Delhi.

Articles / Papers:

Abrol, Dinesh, Pramod Prajapati and Nidhi Singh (2011). “Globalization of the

Indian Pharmaceutical Industry: Implications for the direction, distribution and

diversity in drug innovation”, International Journal of institutions and

Economics, 3(2) (National Institute of Science, Technology and Development

Studies, New Delhi).

Acemoglu, Daron, and Joshua Linn (2004). “Market Size in Innovation: Theory

and Evidence from the Pharmaceutical Industry”, Quarterly Journal of

Economics. (August).

Agarwal, Abhinav, Kamal Dua, Vaibhav Garg, U.V.S. Sara Akash Taneja

(2006). “Challenges and Opportunities for the Indian pharma industry”, Health

Administrator, XX (1&2).

Aggarwal, Aradhna (2004). “Strategic Approach to Strengthening the

International Competitiveness in the Knowledge Based Industries : The Indian

Pharmaceutical Industry”, Research and Information System for the Non-

Aligned and other Developing Countries, Discussion Paper # 80/2004, New

Delhi (September).

Aggarwal, Aradhna (2007). Paper presented at the seminar on India and

Globalization: A seminar in Honour of Professor N.S. Siddharthan, New Delhi.

Bibliography

221

Agosin, M.R. and Ricardo Mayer (2000). “Foreign Investment in Developing

Countries: Does it Crowd in Domestic Investment?”, UNCTAD Discussion

Paper # 146, Geneva, UNCTAD.

Aitken, Brian J. and Ann E. Harrison (1999). “Do domestic firms Benefits from

Direct Foreign Investment? Evidence from Venezuela”, American Economic

Review, 89.

Amin, B.D. (1939). “The rise and growth of the Alembic Chemical Works”,

Baroda, Alembic Chemical Work.

Anand, Nitya (1988). “Drug Research and CSIR, Drugs and Pharmaceuticals:

Industry Highlights”, Lucknow (January).

Antonakis, K. (2001). “The dynamics of technological innovation: the case of the

pharmaceutical industry”, Research Policy, 30.

Athreye, S. and Kapur (2001). “Private Foreign Investment in India, Pain or

Panacea?”, World Economy, 24.

Athukorala, P., S. Jayasuriya and E. Oczkowski (1995). “Multinational Firma

and Export Performance in Developing Countries: Some Analytical Issues and

New Empirical Evidence”, Journal of Development Economics, 46.

Attaran, A. ( 2004). “How do patents and economic policies affect access to

essential medicines in developing countries?”, Health Affairs 23(3).

Bajpai, N. and J.D. Sachs (2000). “ Foreign Direct Investment in India : Issues

and Problems”, Harvard Institute for International Development, Development

Discussion Paper #759, Harvard University (March).

Balasubramanyam, V.N. and David Sapsford (2007). “Does India a lot more

FDI?”, Economic and Political Weekly, Sameeksha Trust Publication, Mumbai

XLII (17).

Baldia, Sonia (2007). "Knowledge Process Outsourcing to India: Important

Considerations for U.S. Companies”, In Doing Business in India: Critical Legal

Bibliography

222

Issues for U.S. Companies, by Ashish S Prasad and Mark L Shwartz, Practicing

Law Institute, New York.

Basu, P., N.C. Nayak, Archana (2007). “Foreign Direct Investment in India

Emerging Horizon”, Indian Economic Review, Mumbai, XXXXII (2).

Bergman, Annika (2006). “FDI and Spillover Effects in the Indian Pharmaceutical

Industry”, Research and Information System for the Non-Aligned and other

Developing Countries, Discussion Paper # 113, New Delhi (August).

Biospectrum (2008). “Rethinking R&D”, May7,

www.biospectrum.indiaciol.com/context/biobusiness/10805076.asp.

Blomstrom, M. and Ari kokko (2005). “The Economics of Foreign Direct

Investment”, NBER Working Paper # 168, National Bureau of Economic

Research, Cambridge.

Blomstrom, Magnus and Ari Kokko (1997). “Regional integration and Foreign

Direct Investment”, World Bank Policy Research, Working Paper # 1750,

Cambridge.

Blomstrom, Magnus, H. Persson (1983). “Foreign investment and Spillover

Efficiency in an Underdeveloped Economy: Evidence from the Mexican

Manufacturing Industry”, World Development, 11.

Blomstrom, Magnus, Steven Globerman, Ari Kokko (1999). “The determinants

of Host Country Spillovers from Foreign Direct Investments: Review and

Synthesis of the Literature”, The European Institute of Japanese Studies,

Stockholm School of Economics, Working paper # 76.

Bloodgood, Laura (2007). “Competitive Conditions for Foreign Direct investment

in India”, US International Trade Commission, Office of Economics,

Washington DC.

Boddewyn, J.J. (1985). “Theories of Foreign Direct Investment and Disinvestment:

A Classificatory Note”, Management International Review 25(1).

Bibliography

223

Bransteeten, Lee, R.Fisman, C.Foley, and K.Saggi. (2007). “Intellectual

Property Rights, Imitation and Foreign Direct Investment: Theory and

Evidences”, NBER, Working Paper # 13033, National Bureau of Economic

Research, Cambridge.

Budget (2007-08). Ministry of finance, Government of India, New Delhi

www.india.budget.nic.in.

Business Standard (2011). “Ministries debate FDI in Pharma”, 26 April, New

Delhi.

Calvet, A.L. (1981). “A synthesis of foreign direct investment theories and theories

of the multinational firm”, Journal of International Business Studies

(Spring/Summer).

Chadha, Alka (2006). “Destination India for the Pharmaceutical Industry”, Delhi

Business Review, 7 (1).

Chaturvedi, Ila (2011). “Role of FDI in Economic Development of India: Sectoral

Analysis”, International Conference on Technology and Business Management,

Jaipuria Institute of Management, Ghaziabad (28-30th March).

Chaturvedi, Kalpana and Joanna Chatway (2006). “Strategic Integration of

Knowledge in Indian Pharmaceutical firms: creating competencies for

innovation”, International Journal Business Innovation and Research, 1(1/2).

Chaturvedi, Kalpana, Joanna Chataway and David Wield (2007). “Policy,

Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms”,

Technology Analysis and Strategic Management, 19 (5).

Chaudhuri, Sudip (1997). “The Evolution of the Indian Pharmaceutical

Industry”, in G.Felker et al. (eds) The Pharmaceutical Industry in India and

Hungary: Policies, Institutions and Technological Development, World Bank

Technical Paper # 392.

Bibliography

224

Chaudhuri, Shubham, Pinelopi K. Goldberg, and Panle Jia (2006). "Estimating

the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of

Quinolones in India”, The American Economic Review (American Economic

Association), December, 96(5).

Chaudhuri, Sudip (1984). “Manufacturing Drugs Without TNCs: Status of

Indigenous Sector in India”, Economic and Political Weekly, Sameeksha Trust

Publication, Mumbai, XIX (31, 32, and 33).

Chhibber, Pradeep K., and Sumit K. Majumbdar(1999). "Foreign Ownership

and Profitability: Property Rights, Control, and the Performance of Firms in

Indian Industry”, Journal of Law and Economics, The University of Chicago

Press, 42(1) (April).

Coase, R.H. (1937), “The Nature of the Firm”, Economica, 4(16). (November).

Confederation of Indian Industry (2000). Foreign Direct Investment in India:

How can $ 10 billion of Annual Inflows be Realized, New Delhi, (January).

Confederation of Indian Industry (2002). From Crumbs to Riches: Reorienting

Foreign Direct Investment in India, 2002, New Delhi.

Davidson, Larry and Gennadiy Greblov (2005). “The Pharmaceutical Industry in

the Global Economy”, Indiana University Kelly School of Business

Bloomington, Indiana.

De Mello, Jr. Luiz R. (1999). “Foreign direct investment-led growth: evidence

from time series and panel data”, Oxford Economic Papers, 51.

Department of Pharmaceutical (2009). Annual Report 2009-10, Ministry of

Chemical and fertilizers, Government of India. New Delhi. www.pharma.nic.in.

Bibliography

225

Dhar, Biswajit and C. Niranjan Rao and Veena Gupta (2002). “Transfer of

Technology for Successful Integration into the Global Economy: A Case Study

of the Pharmaceutical Industry in India”, United Nations, New York and

Geneva.

Dhar, Biswajit and Niranjan Rao (2002). “Transfer Technology for Successful

Integration into the Global Economy: A Case Study of the Indian

Pharmaceutical Industry”, UNCTAD Working Paper # 22, United Nations,

Geneva.

DiMasi, J.A., R.W. Hansen, and H.G. Grabowski (2003). “The Price Innovation:

New Estimates of Drug Development Costs”, Journal of Health Economics,

22(2).

Directory of Pharmaceutical Manufacturing Units in India (2007), National

Pharmaceutical Pricing Authority, Government of India, New Delhi.

http://www.nppaindia.nic.in.

Doing Business Report (2011). World Bank, Washington DC.

Dubey, D.P. (1996). “Globalization and its Impact on the Indian Pharmaceutical

industry”, www.revolutionarydemocracy.org/rdv5n1/pharmacy.htm .

Dunning, J.H. & A.M. Rugman (1985). “The Influence of Hymer's Dissertation on

the Theory of Foreign Direct Investment”, American Economic Review, 75(2).

Dunning, J.H. (1981). “Explaining the International Direct Investment Position of

Countries: Towards a Dynamic or Developmental Approach”,

weltwirtschaftliches Archiv, 117.

Dunning, John H. (1979). “Explaining Changing Pattern of International

Production in Defence of Eclectic Approach”, Oxford Bulletin of Economics

and Statistics, 41.

Bibliography

226

Dunning, John H. (1988). “The Eclectic Paradigm of International Production-A

Restatement and Some Possible Extension”, Journal of International Business

Studies, 19 (spring).

Duperon, Williom O. and E. Mine Cinar (2010). “Global Competition Versus

Regional Interest: FDI and Pharmaceuticals in India”, Journal of International

Commercial Law and Technology, 5(4).

Economist (2005). “Prescription for Change: A Survey of Pharmaceuticals”,

Economist, 18-24 (June).

Economist Intelligence Unit (2011). “World investment prospects to 2011-

Foreign direct investment and the challenge of political risk”, Written with the

Columbia Program on International Investment,CEI-DR,Dominican Republic

Export & investment Centre.www.cei-rd.gov.do

Ernst & Young (2010). “Doing Business in India”, Ernst &Yong Pvt Ltd, Kolkata,

www.ey.com/india.

Expert–Import Bank of India (2007). “Indian Pharmaceutical Industry, Surging

Globally”, Occasional Paper # 119, Quest Publication (August).

Express Pharma (2007). “Shaping SEZ”, 16-31 December, Fortnightly insight for

pharma professionals. www.expresspharmaonline.com.

Express Pharma (2008). “Budget Speak 2008-09”, 16-31, March, Fortnightly

insight for pharma professionals. www.expresspharmaonline.

Express Pharma (2010). “India’s CIS business meet held in Mumbai”, 1-15

August. Fortnightly insight for pharma professionals.

www.expresspharma.online.com.

Express Pharma (2010a). “Strategic Partners in Prosperity: All CRAM Med up”,

Fortnightly insight for Pharma Professionals, 16-31

July.www.expresspharma.online.com.

Bibliography

227

Express Pharma (2011). “Cap on FDI in pharma industry- Is it necessary?”, 1-15

February, Fortnightly insight for pharma professionals,

www.expresspharmaonline.com.

Federation of Indian Chambers of Commerce & Industry (2001). “The

Experience of Foreign Direct Investors in India”, New Delhi (April).

Feinberg, Susan E. and Sumit K. Majumdar (2001). “Technology spillovers from

Foreign Direct Investment in the Indian Pharmaceutical Industry”, Journal of

International Business Studies, Third Quarter, 32(3).

Felker, Greg. Shekhar Chauduri, Katalin Gyorgy (1997). “The Pharmaceutical

Industry in India and Hungary-Policies: Institutions and Technological

Development”, World Bank paper # 392.

FICCI (2005). “Competitiveness of the Indian pharmaceutical industry in the new

product patent Regime”, FICCI Report for National Competitiveness Council,

New Delhi (March).

Fink, C. (2000). “How stronger patent protection in India might affect the

behaviour of transnational pharmaceutical industries”, working paper # 2352,

World Bank Washington, D.C.

Flowers, E. B. (1976). “Oligopolistic Reactions in European and Canadian Direct

Investment in the United States”, Journal of International Business Studies, 7.

Fry, Maxwell J. (1993). “Foreign Direct Investment in a Macro Economic

Framework – Finance, Efficiency, Incentives and Distortions”, World Bank,

Policy Research Working paper, # 1141, Washington D.C.

Glass, Amy Jocelyn and Kamal Saggi (2002). “Intellectual Property Rights and

Foreign Direct Investment”, Journal of International Economics, 56.

Global Business Policy Council (2001). “FDI Confidence Audit: India”,

Alxandric, Virginia, A.T. Kearney, Inc., USA.

Global Business Policy Council (2005). “FDI Confidence Index”, 8, GBPC.

Bibliography

228

Grabowski, Henry (2002). “Patents, Innovation and Access to New Medicines”,

Journal of International Economic Law, 5(4), December.

Grace, Cheri (2004). “The Effect of Changing Intellectual Property on

Pharmaceutical Industry Prospects in India and China: Considerations for

Access to Medicines”, Government, Department for International Development,

DFID Health Systems Resource Centre, London, Fretwells Ltd.

Graham, Edward M. (1974). “Oligopolistic reaction and European direct

investment in the United States”, Harvard Business School.

Graham, Edward M. and Paul R. Krugman (1989). “Foreign Direct Investment

in U.S.”, Washington Institute for International Economies.

Gupta, S., H. Davoodi, and E. Tiongson (2000). “Corruption and the Provision of

Health Care and Education Services”, IMF Working Paper # 116, Washington:

International Monetary Fund.

Gupta, S., H. Davoodi, and R. Alonso-Terme, (1998). “Does Corruption Affect

Income Inequality and Poverty?”, IMF Working Paper # 76, Washington,

International Monetary Fund.

Hamied, Y.K. (1993). “Patents and the Pharmaceutical industry: A Review”,

Presentation at the international conference on patents regime, Cipla Ltd, New

Delhi.

Handa, Kewal (2011). “Should FDI in pharma be regulated?”, 8th April, Financial

Express.

Hasan, R., D. Mitra and K. V. Ramaswamy ( 2003). “Trade Reforms, Labor

Regulations and Labor- Demand Elasticities: Evidence from India”, NBER

Working Paper 9879, (July).

Haskel, E. Jonathan, C.S. Pereria, and J.M. Slaughter (2004). “Does Inward

Foreign Direct Investment Boost the Productivity of the Domestic Firms”,

Bibliography

229

NBER, Working Paper # 8724, National Bureau of Economic Research,

Cambridge.

Hathi Committee (1975). “Report of the committee on Drugs and Pharmaceuticals

Industry”, Ministry of Petroleum and Chemical, New Delhi.

Helpman, E. and P.R. Krugman (1985). “Market Structure and Foreign Trade”,

The Massachusetts Institute of Technology Press, Cambridge.

Helpman, Elhanan (2006). “Trade, FDI and the organization of firms”, Journal of

Economic Literature, XLIV(3).

Henrik, Hansen and Rand John (2006). “On the Causal Links between FDI and

Growth in Developing Countries”, World Economy, 29.

Hu, Peng (2006). “India’s Suitability for Foreign Direct Investment”, Working

Paper # 553, International Business with Special Reference to India, University

of Arizona.

Husain, Shahbaaz (2012). “Foreign Direct Investment in Indian Pharmaceutical

Industry”, Research Paper, Symbiosis Law School, Pune (10th January).

Hymer, S. H. (1976). “The international operations of national firms: A study of

direct foreign investment “, Cambridge, MA: MIT Press (1960).

IBEF & Ernst & Young (2010), “Pharmaceuticals”, April,Haryana.www.ibef.org.

IBEF (2008). “Pharmaceuticals: December, 2008”, Indian Brand Equity

Foundation (www.ibef.org).

IBEF (2010). “Pharmaceuticals”, April, Indian Brand Equity Foundation.

www.ibef.org.

ICRA (2002). “ICRA Industry Watch Series -The Indian Pharmaceutical Industry”,

compiled by ICRA Information Services, ICRA, Mumbai.

Bibliography

230

ICRA Ltd. (2004). “Industry Watch: The Indian Pharmaceutical Industry”,

Information and Credit Rating Agency, New Delhi.

Idea & Insights (2011). “Did liberalization help India's Pharma Industry?”, April,

Indian Institute of Management , Bangalore.

IMF (2004). “Foreign Direct Investments, Trends, Data Availability, Concepts and

Recording Practices”, IMF, 9th February, (online).

India Infoline (2000). “Contract manufacturing: Growth Engine for Indian

Pharma Companies?”, 16th August .

India Infoline (2004). “Dr. Reddy`s Research Foundation Pharmacophore”,

Address by K.A. Reddy, 17th January.

http;//www.indiainfoline.com/nevi/rere.html.

Iyer, Parvathi. K.(2008). “Structure and Performance of Small and Medium Scale

Pharmaceutical Firms”, S&T and Industry, India, Science and Technology.

James, B.G. (1977). “The Future of Multinational Pharmaceutical Industry in

1990”, Associated Business Programmes Ltd. London.

Jayasuriya, D.C. (1985). “Regulation of Pharmaceuticals in developing countries

Legal Issues and Approaches”, WHO, Geneva.

Jha, Ravinder (2007). “Options for Indian Pharmaceutical Industry in the

Changing Environment”, Economic and Political Weekly, Sameeksha Trust

Publication, Mumbai, XLII (39).

Johnson, Andreas (2004). “The Effects of FDI Inflows on Host Country Economic

Growth”, http://www.infra.kth.se\cesis\research\publications\working

Joseph, Reji K. (2011). “The R&D Scenario in Indian Pharmaceutical Industry”,

RIS DP#176, Research and Information System for Developing Countries, New

Delhi (December).

Bibliography

231

Joshi, Hemant N. (2003). “Analysis of the Indian Pharmaceutical Industry: With

Emphasis on Opportunities in 2005”, Pharmaceutical Technology (January).

Kalsekar, Mahesh (2003). “The Indian Pharmaceuticals Market – An Overview”,

ORG-MARG, AC Nielson, Mumbai.

Kathuria,V. (2002). “Liberalization, FDI and Productivity Spillover: An Analysis

of Indian Manufacturing Firms”, Oxford Economic Paper, 54(4).

Katrak, H. (1985). “Imported technology, enterprise size and R&D in a newly

industrializing country: The Indian experience”, Oxford Bulletin of Economics

and Statistics (August).

Katrak, H. (1989). “Imported technologies and R&D in a newly industrializing

country: the experience of Indian enterprises”, Journal of Development

Economics, 31 (1).

Katrak, H. (1990). “Imports of technology and the technological effort of Indian

enterprises”, World Development, 18(3).

Khan, A.Q. (1999). “Emerging Dimensions of Global Fund Flows Management: A

Focus on India”, Unpublished Project, Department of Commerce AMU,

Aligarh.

Kiran, Ravi and Sunita Mishra (2009). “Performance of the Indian

Pharmaceutical Industry in Post TRIPs Period: A Firm Level Analysis”,

International Review of Business Research Paper, Nonmember, 5(6).

Kirim, A.S. (1985). “Reconsidering Patents and Economic Development: A case

study of the Turkish Pharmaceutical Industry”, World Development, 13(2)

(February).

KMPG (2008). “Investing in India”, KPMG_in_India, in.kpmg.com.

Knickerbocker, Fredric T. (1973). “Oligopolistic Reaction and Multinational

Enterprises, Boston: Division of Research”, Harvard University Press, Graduate

School of Business Administration.

Bibliography

232

Knowledge@Wharton (2006). “Where will Indian Drug Companies be in Five

Years? Everywhere – If They Innovate”, Report Prepared by

Knowledge@Wharton in collaboration with Bain & Company, at <www. bain.

com/ bainweb/ pdfs / cms /marketing /

bain%20India%20Pharma%20FINAL%203-21 06.pdf>, accessed 16 September

2006.

Kojima, Kiyoshi and, Turutomo Ozawa (1984). “Micro and Macro-Economic

Model of Direct Foreign Investment towards a Synthesis”, Hitotsuabashi

Journal of Economics, 25 (June 25).

Kokko, A., Ruben Tansini and Mario C. Zejan (1996). “Local Technological

Capacity and Productivity Spillovers from FDI in the Uruguayan

Manufacturing Sector”, The Journal of Development Studies, 32(4).

Kumar, N. and M. Saqib (1996). “Firm size, opportunities for adaptation and in-

house R&D activity in developing countries: the case of Indian manufacturing”,

Research Policy, 25(5).

Kumar, Nagesh (1991). “Mode of rivalry and comparative behaviour of

multinational and local enterprises: The case of Indian manufacturing”, Journal

of Development Economics, 35.

Kumar, Nagesh (1998). “Liberalization and Changing Patterns of Foreign Direct

Investments: Has India’s Relative Attractiveness as a Host of FDI Improved?”,

Economic and Political Weekly, Sameeksha Trust Publication, Mumbai, 33(22).

Kumar, Nagesh (2001). “Infrastructure Availability FDI Inflows and their Export

Orientation: A Cross Country Exploration”, Research and Information System

for Developing Countries # 1.2 (20th November).

Kumar, Nagesh (2001a). “WTO Regime, Hot Country Policies and Global

Patterns of MNE activity: Recent Quantitative Studies and India’s Strategic

Response”, Economic and Political Weekly, Sameeksha Trust Publication,

Mumbai, XXXVI(1).

Bibliography

233

Kumar, Nagesh (2003). “Intellectual Property Rights, Technology and Economic

Development: Experiences of Asian Countries”, Economic and Political

Weekly, Sameeksha Trust Publication, Mumbai, XXXVIII (3).

Kumar, Nagesh (2005). “Liberalization, Foreign Direct Investment Flows &

Development: Indian Experience in the 1990s”, Economic and Political Weekly,

Sameeksha Trust Publication, Mumbai XXXX (14).

Kumar, Nagesh and Jaya Prakash Pradhan (2002). “Foreign Direct Investment,

Externalities and Economic Growth in Developing Countries: Some Empirical

Explorations and Implications for WTO Negotiations on Investment”, Research

and Information System for Developing Countries Discussion Paper # 27/2002.

Kumari, Anita (2007). “Liberalization, TRIPs and Technological Behavioiur of

Firms in Indian Pharmaceutical Industry”, International Review of Business

Research Papers, 3 (1) (March).

Lalitha, N. (2002). “Indian Pharmaceutical Industry in WTO Regime: A SWOT

Analysis”, Economic and Political Weekly, Sameeksha Trust Publication,

Mumbai XXXVII (34).

Lalitha, N. (2002a). “TRIPS and Pharmaceutical Industry: issues of Strategic

Importance”, Review of Development and Change, I (7).

Lall, S. and P. Streeten (1977). “Foreign Investment Transnational’s and

Developing Countries”, Macmillan, London.

Lall, Sanjay (1974). “International Pharmaceutical Industry and Less Developed

Countries: II-Costs and alternatives”, Economic and Political Weekly,

Sameeksha Trust Publication, Mumbai IX (48).

Lanoszka, Anna (2003). “The Global Politics of Intellectual Property Rights and

Pharmaceutical Drug Policies in Developing Countries”, International Political

Science Review, Sage Publications 24 (2) (April).

Bibliography

234

Laura, Alfaro (2003). “Foreign Direct Investment and Growth: Does the Sector

Matter?”, Harvard Business School (April).

Li, Ling, Lan Kang and Shilpa Gentela (2008). “China Versus India– Reality

Check for Pharma R&D”, The Korn/Ferry International.

www.kornferryasia.com.

Lizondo, Saul J. (1991). “Foreign Direct Investment”, in Occasional Paper 77, A

Study by the Research Department of the IMF (March).

Lyamota, Koji (2003). “Human Capital Formation and FDI in Developing

Countries”, OECD Working Paper # 211, OECD Development Centre.

Mansfield, E. (1994). “Intellectual Property Protection Foreign Direct Investment

and Technology Transfer”, IFC Discussion Paper 19, Washington D.C., World

Bank.

Markusen, J.R. (1995). “The Boundaries of MNEs and the Theory of International

Trade”, Journal of Economic Perspective 9.

Markusen, J.R. and A.J. Venables (1997). “Foreign Direct Investment as a

Catalyst for Industrial Development”, National Bureau of Economic Research,

1050 Massachusetts Avenue, Cambridge.

Mashelkar Committee (2003). “Report of the Export Committee on a

comprehensive examination of Drug Regulatory Issues, Including the problem

of spurious drugs”, New Delhi, Government of India, Ministry of Health and

Family Welfare, Para 6.3.4.

Maskus, Keith (1998). “The Role of IPRs in Emerging FDI and Technology

Transfer. In Strengthening IPRs in Asia: Implications for Australia”, Australian

Economic Paper # 346, University of Colorado, Australia.

Mathiyazhagan, Maathai K. and Dukhabandhu Sahoo (2008). “Do Foreign

Direct Investment Inflows Benefits the Major Sectors in India?”, ISAS Working

Paper # 38, National University of Singapore (NUS), Singapore (18th February).

Bibliography

235

Mayaram, Arvind (2004). “Don’t let go of the foreign Hand”, The Economic

Times, 6th August.

McKinsey & Company (2001). Achieving Quantum Leap in India’s FDI,

McKinsey Global Institute, New York (June).

McKinsey & Company (2001a). Identifying the Barriers to Rapid Employment

and Output Growth in India, McKinsey Global Institute, New York (June).

Ministry of Petroleum and Chemicals (1971). “Drugs Prices Control: Aims &

Achievements”, Government of India, New Delhi.

Mohiuddin, Yasmin (2003). “Foreign Direct Investment: A Comparison of India

and China”, International Seminar on Business Education in the New

Millennium, held at Department of Commerce, AMU, Aligarh (March 1st -2nd) .

Moon, Hwy-Chang and Thomas W. Roehl (2001). “Unconventional foreign

direct investment and the imbalance theory”, International Business Review 10.

Nair, M.D. (2011). “Fast Emerging Trends in the Global Pharmaceutical

Industry”,The Pharma review, Kongposh publication Pvt. Ltd, New Delhi

(November- December).

Narayana, P.L. (1984). “The Indian Pharmaceutical Industry: Problems and

Prospects”, National Council of Applied Economic Research (NCAER), New

Delhi.

National Pharmaceutical Policy (2006), Department of Chemical and

Petrochemicals, Government of India, 2005, Part-A (28th December).

Nayyar, Deepak (1978). “Transnational Corporation and Manufactured Exports

from the poor countries”, The Economic Journal.

Nigel Pain & Wakelin Katharine (1998). “Export Performance and the Role of

Foreign Direct Investment”, The Manchester School, 66.

Bibliography

236

NIHCM (1999). “Factors affecting the growth of prescription drugs expenditures;

Issue brief”, Ministry of Health & Family Welfare, National institute of Health

Care Management Foundation (July).

Norgue, J. (1990). “Patents and Pharmaceuticals Drugs: Understanding the

Pressures on developing countries”, Journal of world Trade, World Bank

Washington 24(6).

OPPI (2005). “Speech of the Persident Mr. Ranjit Shahani”, 39th Annual General

Meeting, Mumbai (September 24th).

ORG-MARG (2004). “ORG IMS Retail Store Audit for Pharmaceutical Products

in India”, ORG-MARG Private Limited, AC Nielson, December, Baroda.

Patnaik, Anabadhya, Kshitij Chanana, Nakul Kapoor Praful Singhal and

Sudhanshu Pandey (2009). “Indian Pharmaceutical Sector”, Project Report;

Managerial Economics, IBS Hyderabad (10th September).

Pharmaceutical Policy (2002). Department of Chemical and Fertilizer,

Government of India, New Delhi.

Pradhan, J.P. (2002). “FDI spillovers and local productivity growth evidence from

Indian pharmaceutical Industry”, Artha Vijnana, XLIV (3-4) & MPRA Paper #

17080 (September).

Pradhan, J.P. (2003). “Liberalization Firm Size and R&D Performance: A Firm

Level Study of Indian Pharmaceutical Industry”, Research and Information

System for the Non-Aligned and other Developing Countries, Discussion Paper

# 40/2003, New Delhi.

Pradhan, J.P. (2006). “Global competitiveness of Indian pharmaceutical Industry.

Trends and Strategies”, ISID Working paper 2006/05, New Delhi (June).

Pradhan, J.P. (2006). “Quality of foreign direct investment, knowledge spillovers

and host country productivity”, ISID Working Paper # 2006 /09, Institute for

Studies in Industrial Development, New Delhi,

Bibliography

237

Pradhan, J.P. and Abhinav Alakshendra (2006). “Overseas acquisition versus

Greenfield foreign investment – which Inter nationalization strategy is better for

Indian pharmaceutical Enterprises?”, ISID working paper 2006/07, Institute for

Studies in Industrial Development, New Delhi (August) .

Pradhan, J.P., Keshab Das and Mahua Paul (2006). “Export-Orientation of

Foreign Manufacturing Affiliates in India: Factors, Tendencies and

Implications”, ISID Working Paper 2006/08, Institute of Studies in Industrial

Development, New Delhi (August).

Pratiyogita Darpan (2009). “General Studies: Indian economy”, Upkar

Publications, Agra.

Priolkar Subodh (2009). “Can India be Pharmaceutical Superpower in 2020?”,

Pharma Times, 41(1) (January).

Rai, Rajnish Kumar (2009). “Effects of the TRIPs Mandated Intellectual Property

Rights on Foreign Direct Investment in Developing Countries: A case study of

the Indian Pharmaceutical Industry”, The Journal of World Intellectual

Property, 11(5-6). http://dx.doi.org/10.1111/j.1747-1796.2008.00340.x.

Raizada B. (2002). “Intellectual Property, Technology and Policy Framework –

Experience of India in the Pharmaceutical Sector”, Document prepared for the

WIPO national Seminar on Industrial Property and the Patent Cooperation

Treaty (PCT) organized by the World Intellectual Property Organization

(WIPO) in cooperation with the Republic of Mauritius Port-Louis (15th and 16th

July).

Rao, K.S., M.R. Chalapati , Murthy and K.V.K. Ranganathan (1999). “Foreign

Direct Investments in the Post Liberalization Period: An Overview”, Journal of

Indian School of Political Economy, ISID, New Delhi, 11(3) (July-September).

Rau, B.S. and P.V. Appaji (2012). “Global Pharmaceutical Trade and

Contribution of India”. The Pharma review, Kongposh publication Pvt. Ltd,

New Delhi

Bibliography

238

Ray, Tapan (2010). “Indian Pharmaceutical Market in a New Paradigm :Win

some and Win some more”, Director General Organization of Pharmaceutical

Producers of India, DHL 10th Life Science & Healthcare Conference &

Workshop 21st – 23rd September , Dubai.

Report (2006). “Impact of TRIPs on pharmaceutical price: with Specific focus on

generics in India”, NIPER, Project under the work plan of the WHO Biennium

2004-05 and ministry of Health and family welfare, Government of India (22nd

April).

Report of the Steering Group on FDI (2002). Planning Commission, Government

of India, Academic Foundation Publication, New Delhi.

Robert, Tancer (1999). “Investing in the Pharmaceutical Industry”, The American

School of International Management.

Robin, M. Leichenko & A. Erickson Rodney (1997). “Foreign Direct Investment

and State Export Performance”, Journal of Regional Science, 37.

Romer, Paul M. (1993). “Idea Gaps and Objects Gaps in Economic

Development”, Journal of Monetary Economics, 32.

Roumeliotis Gregouy (2006). “India geared up for unprecedented manufacturing

growth”, in Pharma Technology. Com (15th August).

Rugman, Alan M. (1980). “International as a General Theory of Foreign Direct

Investment: A Re-appraisal of the Literature”, Weltwirtschaftliches Archive,

116, Heft 2.

Sagar, B.P.S., R. Zafar and Aklavya Singh (2006). “Counterfeit, fake and

Spurious Drugs”, Health administrator, XIX (1).

Sakakibara, Mariko and Lee Branstetter (2001). “Do stronger patent induce

more innovation? Evidence from the 1988 Japanese Patent law reforms”,

Journal of Economics, 32(1) (spring).

Bibliography

239

Scherer, Frederic M. (1993). “Pricing, Profits, and Technological Progress in the

Pharmaceutical Industry”, Journal of Economic Perspectives, 7(3) (summer).

Schneider, F. and B. Frey (1985). “Economic and Political Determinants of

Foreign Direct Investment”, World Development, 13.

Sengupta, N.K., A. Banik and R. Kathuria (1997). “Qualitative Aspects of FDI

Inflows: The Case of India”, The Economic Times, 7th January.

Serven, Luis and Soliman Andres (1992). “Private investment and macro

economic adjustment – A Survey”, World Bank Research Observer, 7.

Shanmugasundaram, G. (2011). “Foreign Direct Investment and Small Scale

Drug Industry in India”, The Pharma review, Kongposh publication Pvt. Ltd,

New Delhi (May-June).

Sharma, K. (2000). “Export Growth in India: Has FDI Played a Role?”,

Economic Growth Centre Discussion Paper # 816, Yale University.

Singh, Kulwinder (2005). “Foreign Direct Investment in India: A Critical Analysis

of FDI From 1991-2005”, Centre for Civil Society, Research internship

Programme. New Delhi.

Singh, Malvinder Mohan (2006). “Will India become the global centre for

pharmaceutical research & development?”, Journal of Generic Medicines: The

Business Journal for the Generic Medicines Sector DOI:

10.1057/palgrave.jgm.4940119 ,3 (3): 194-200, Sage Publication, New Delhi.

http://jgm.sagepub.com/content/3/3/194.

Sjoholm, F. (1999). “Technology, Gap, Competition and Spillover from Direct

Foreign Investment: Evidence from Establishment Data”, The Journal of

Development Studies, 36(1) (October).

Srinivasan, S. (2011). “Dangers of FDI in pharma”, October 13, Business Line,

The Hindu.

Bibliography

240

Sun, Haishun (2001). “Foreign Direct Investment and Regional Export

Performance in China”, Journal of Regional Science, 41.

Tanzi, V. and H. Davoodi (1997). “Corruption, Public Investment and Growth”,

IMF Working Paper # 139. Washington, International Monetary Fund.

Topalova, P. (2004). “Trade Liberalization and firm productivity: the case of

India”, IMF Working Paper WP/04/28.

Tripathy, Ishita G, Surendra S. Yadav and Seems Sharma. (2011). “FDI

Inflows into Indian Pharmaceutical Industry: An Analysis of Trends and

Constraints”, Journal of Intellectual Property Rights (16th July).

Tsai, Pan-Long (1991). “Determinants of FDI in Taiwan: an Alternative Approach

with Time Series data”, World Development, 14.

Tybout, J. and M. Westbrook (1995). “Trade Liberalization and the Dimensions

of Efficiency Change in the Mexican Manufacturing Industries”, Journal of

International Economics, 39.

UNCTAD (2007). “World Investment Prospects Survey 2007-09”, New York and

Geneva, United Nations.

Unel, Bulent (2003). “Productivity Trends in India’s Manufacturing Sectors in the

Last Two Decades”, IMF Working Paper, WP/03/22.

Vachani, Sushil (1997). “Economic liberalization’s effect on sources of competitive

advantage of different groups of companies: The case of India”, International

Business Review, 6(2) (April).

Vernon, Reynold (1966). “International Investment and International Trade in the

Product Cycle”, Quarterly Journal of Economics, 80. (May).

Wheeler Avid and Mody Ashoka (1992). “International Investment location

Decisions: The case of U.S firms”, Journal of International Economics, 33.

Bibliography

241

World Bank (1997). “Malaysia Enterprise Training, Technology and

Productivity”, A world bank Country Study, Washington DC.

World Economic Forum (2008). “The Global Competitiveness Report”, 2007-

2008.

World Investment Report (1995). “Transnational Corporations and

Competitiveness”, UNCTAD, New York and Geneva, United Nations.

World Investment report (1999). “FDI and the Challenges of Development”,

UNCTAD, New York.

World Investment Report (2001). “Promoting linkages”, UNCTAD, New York

and Geneva, United Nations.

World Investment Report (2003). “FDI Policies for Development: National and

International Perspective”, UNCTAD, New York and Geneva, United Nations.

World Investment Report (2004). “The shift towards services”, UNCTAD, New

York and Geneva, United Nations.

World Investment Report (2008). “Transnational Corporations and the

Infrastructure Challenge”, UNCTAD, New York and Geneva, United Nations.

World Investment Report (2009). “Transnational Corporations, Agricultural

Production and Development”, UNCTAD, New York and Geneva, United

Nations.

World Trade Organization (2009). “International Trade Statistics”, Annual

Trade Statistics, Statistics Database, World Trade Organization, Geneva.

World Trade organization (2010). “International Trade Statistics 2010”, ISBN

978-92-870-3739-8 Switzerland. www.wto.org.

Yes Bank and OPPI Report (2009). “Indian Pharmaceutical Industry: vision

2015”, Yes Bank Ltd. & OPPI, Mumbai.

Bibliography

242

Websites:

http://dipp.nic.in

http://dipp.nic.in/fdi_statistics/india_fdi_index.htm

http://en.wikipedia.org

http://finmin.nic.in/capital_market/capital_market.asp

http://planningcommission.gov.in

http://www.ficci.org.in.

http://www.ibef.org

http://www.indianindustry.com

http://www.startbizindia.in/india_fdi_trend.php

www.amezon.com

www.drreddys.com

www.expresspharma.online.com.

www.indiabudget.nic.in

www.industrychannel.com

www.lupin.com

www.piramalhealthcare.com

www.ranbaxy.com

www.sunpharma.com

www.unctad.org

www.wockhardt.com